US4695578A
(en)
*
|
1984-01-25 |
1987-09-22 |
Glaxo Group Limited |
1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
|
AU583343B2
(en)
*
|
1985-01-23 |
1989-04-27 |
Glaxo Group Limited |
Heterocyclic compounds
|
EP0201165B1
(en)
*
|
1985-03-14 |
1994-07-20 |
Beecham Group Plc |
Medicaments for the treatment of emesis
|
GB8516083D0
(en)
*
|
1985-06-25 |
1985-07-31 |
Glaxo Group Ltd |
Heterocyclic compounds
|
US5578628A
(en)
*
|
1985-06-25 |
1996-11-26 |
Glaxo Group Limited |
Medicaments for the treatment of nausea and vomiting
|
GB8518741D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Process
|
GB8518743D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB8518742D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Process
|
US5204356A
(en)
*
|
1985-07-24 |
1993-04-20 |
Glaxo Group Limited |
Treatment of anxiety
|
GB8518745D0
(en)
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB8518658D0
(en)
*
|
1985-07-24 |
1985-08-29 |
Glaxo Group Ltd |
Medicaments
|
GB8617994D0
(en)
*
|
1986-07-23 |
1986-08-28 |
Glaxo Group Ltd |
Heterocyclic compounds
|
HU895334D0
(en)
*
|
1986-07-30 |
1990-01-28 |
Sandoz Ag |
Process for the preparation of nasal pharmaceutical compositions
|
AT396870B
(de)
*
|
1986-08-07 |
1993-12-27 |
Sandoz Ag |
Verfahren zur herstellung einer galenischen formulierung zur nasalen verabreichung von serotoninantagonisten
|
GB8623819D0
(en)
*
|
1986-10-03 |
1986-11-05 |
Glaxo Group Ltd |
Heterocyclic compounds
|
GB8627909D0
(en)
*
|
1986-11-21 |
1986-12-31 |
Glaxo Group Ltd |
Medicaments
|
DE3777805D1
(de)
*
|
1986-11-21 |
1992-04-30 |
Glaxo Group Ltd |
Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
|
US5202343A
(en)
*
|
1986-11-28 |
1993-04-13 |
Glaxo Group Limited |
Tricyclic ketones useful as HT3 -receptor antagonists
|
GB8812002D0
(en)
*
|
1988-05-20 |
1988-06-22 |
Glaxo Group Ltd |
Chemical compounds
|
GB8628475D0
(en)
*
|
1986-11-28 |
1987-01-07 |
Glaxo Group Ltd |
Medicaments
|
GR871809B
(en)
*
|
1986-11-28 |
1988-03-07 |
Glaxo Group Ltd |
Process for the preparation of tricyclic ketones
|
GB8630079D0
(en)
*
|
1986-12-17 |
1987-01-28 |
Glaxo Group Ltd |
Medicaments
|
IL84845A0
(en)
*
|
1986-12-17 |
1988-06-30 |
Glaxo Group Ltd |
Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
|
US5200414A
(en)
*
|
1986-12-17 |
1993-04-06 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
GB8630071D0
(en)
*
|
1986-12-17 |
1987-01-28 |
Glaxo Group Ltd |
Medicaments
|
US5190954A
(en)
*
|
1986-12-17 |
1993-03-02 |
Glaxo Group Limited |
Methods for the treatment of cognitive disorders
|
JPS63277622A
(ja)
*
|
1986-12-17 |
1988-11-15 |
グラクソ、グループ、リミテッド |
医薬
|
DE3876006T2
(de)
*
|
1987-04-14 |
1993-03-25 |
Glaxo Group Ltd |
Keton-derivate.
|
GB2205745B
(en)
*
|
1987-06-16 |
1990-09-19 |
Nat Res Dev |
Use of dioxopiperidine derivatives as analgesics
|
DE3822792C2
(de)
*
|
1987-07-11 |
1997-11-27 |
Sandoz Ag |
Neue Verwendung von 5HT¶3¶-Antagonisten
|
GB8723157D0
(en)
*
|
1987-10-02 |
1987-11-04 |
Beecham Group Plc |
Compounds
|
CA1304082C
(en)
*
|
1987-10-22 |
1992-06-23 |
Tetsuya Tahara |
Benzoxazine compounds and pharmaceutical use thereof
|
JPH01258673A
(ja)
*
|
1987-10-22 |
1989-10-16 |
Glaxo Group Ltd |
ケトン誘導体
|
US5225431A
(en)
*
|
1987-10-23 |
1993-07-06 |
Burroughs Wellcome Co. |
Therapeutic substituted indole compounds and compositions thereof
|
GB8805269D0
(en)
*
|
1988-03-04 |
1988-04-07 |
Glaxo Group Ltd |
Medicaments
|
JPH0249772A
(ja)
*
|
1988-04-07 |
1990-02-20 |
Glaxo Group Ltd |
イミダゾール誘導体
|
DK185489A
(da)
*
|
1988-04-22 |
1989-10-23 |
Duphar Int Res |
Imidazolylmethyl-cycloalkanoebaaindoloner, deres fremstilling og anvendelse
|
EP0339959A3
(en)
*
|
1988-04-27 |
1991-03-20 |
Glaxo Group Limited |
Lactam derivatives
|
GB8812636D0
(en)
*
|
1988-05-27 |
1988-06-29 |
Glaxo Group Ltd |
Chemical compounds
|
US5290785A
(en)
*
|
1988-09-27 |
1994-03-01 |
Fujisawa Pharmaceutical Co., Ltd. |
Therapeutic agent for ischemic diseases
|
US5173493A
(en)
*
|
1988-09-27 |
1992-12-22 |
Fujisawa Pharmaceutical Company, Ltd. |
Pyridoindole derivatives and processes for preparation thereof
|
AU627221B2
(en)
*
|
1988-09-27 |
1992-08-20 |
Fujisawa Pharmaceutical Co., Ltd. |
Pyridoindole derivatives and processes for preparation thereof
|
FR2639944B1
(fr)
*
|
1988-12-06 |
1991-01-18 |
Adir |
Nouveaux derives de l'indole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
CA2004911A1
(en)
*
|
1988-12-22 |
1990-06-22 |
Mitsuaki Ohta |
4,5,6,7-tetrahydrobenzimidazole derivatives
|
US5223625A
(en)
*
|
1988-12-22 |
1993-06-29 |
Duphar International Research B.V. |
Annelated indolo [3,2,-C]lactams
|
EP0377238A1
(en)
*
|
1988-12-22 |
1990-07-11 |
Duphar International Research B.V |
New annelated indolo (3,2-c)-lactams
|
KR900013959A
(ko)
*
|
1989-03-13 |
1990-10-22 |
원본미기재 |
γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
|
WO1990012569A1
(en)
*
|
1989-04-21 |
1990-11-01 |
Sandoz Ag |
Therapeutic use of 5-ht3 receptor antagonists
|
GB8914804D0
(en)
*
|
1989-06-28 |
1989-08-16 |
Glaxo Group Ltd |
Process
|
US5276050A
(en)
*
|
1989-08-01 |
1994-01-04 |
Glaxo Group Limited |
Medicaments
|
GB8917557D0
(en)
*
|
1989-08-01 |
1989-09-13 |
Glaxo Group Ltd |
Medicaments
|
US5126343A
(en)
*
|
1989-09-11 |
1992-06-30 |
G. D. Searle & Co. |
N-azabicyclo [3.3.0]octane amides of aromatic acids
|
GB2236751B
(en)
|
1989-10-14 |
1993-04-28 |
Wyeth John & Brother Ltd |
Heterocyclic compounds
|
GB8928837D0
(en)
*
|
1989-12-21 |
1990-02-28 |
Beecham Group Plc |
Pharmaceuticals
|
US5187166A
(en)
*
|
1990-07-31 |
1993-02-16 |
Nisshin Flour Milling Co., Ltd. |
Azabicyclo derivatives and their use as antiemetics
|
JPH06508836A
(ja)
*
|
1991-06-26 |
1994-10-06 |
セプラコア,インコーポレーテッド |
光学的に純粋なr(+)オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
|
JPH05310732A
(ja)
*
|
1992-03-12 |
1993-11-22 |
Mitsubishi Kasei Corp |
シンノリン−3−カルボン酸誘導体
|
ES2043535B1
(es)
*
|
1992-03-13 |
1994-08-01 |
Vita Invest Sa |
Procedimiento para la obtencion de la 1,2,3,9-tetrahidro-9-metil-3-(2-metil-1h-imidazol-1-il)metil*-4h-carbazol-4-ona.
|
HU212934B
(en)
|
1992-10-14 |
1996-12-30 |
Richter Gedeon Vegyeszet |
Process for producing novel alkoxalylated carbazolone derivatives
|
CA2106642C
(en)
*
|
1992-10-14 |
2005-08-16 |
Peter Bod |
Carbazolone derivatives and process for preparing the same
|
JPH08507514A
(ja)
*
|
1993-03-08 |
1996-08-13 |
藤沢薬品工業株式会社 |
脳血管性疾患を治療または予防するための薬物
|
GB9310756D0
(en)
*
|
1993-05-25 |
1993-07-14 |
Glaxo Lab Sa |
Compositions
|
GB2327348A
(en)
*
|
1994-06-28 |
1999-01-27 |
Kenneth Francis Prendergast |
Pharmaceutical use of ondansetron
|
GB9423588D0
(en)
*
|
1994-11-22 |
1995-01-11 |
Glaxo Wellcome Inc |
Compositions
|
US6365743B1
(en)
|
1995-10-13 |
2002-04-02 |
Duphar International Research B.V. |
Process for the preparation of enantiomerically pure imidazolyl compounds
|
AU702594B2
(en)
*
|
1995-10-13 |
1999-02-25 |
Duphar International Research B.V. |
Process for the preparation of enantiomerically pure imidazolyl compounds
|
US5969137A
(en)
*
|
1996-09-19 |
1999-10-19 |
Virginia Commonwealth University |
Benzylamidine derivatives with serotonin receptor binding activity
|
CA2371822A1
(en)
|
1999-03-01 |
2000-09-08 |
Sepracor Inc. |
Methods for treating apnea and apnea disorders using optically pure r(+)ondansetron
|
EP1207160A1
(en)
*
|
2000-11-20 |
2002-05-22 |
Hanmi Pharm. Co., Ltd. |
Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
|
AU2003223764A1
(en)
|
2002-04-29 |
2003-11-17 |
Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag |
Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
|
FI6164U1
(fi)
*
|
2003-01-09 |
2004-03-15 |
Synthon Bv |
Ondansetronmuotoja
|
GB2398071B
(en)
*
|
2003-01-24 |
2006-06-07 |
Synthon Bv |
Process for making ondansetron and intermediate thereof
|
ES2238001B1
(es)
*
|
2004-01-21 |
2006-11-01 |
Vita Cientifica, S.L. |
Nuevas formas polimorficas de ondansetron, procedimientos para su preparacion, composiciones farmaceuticas que los contienen y su uso como aantiemeticos.
|
CA2565854A1
(en)
|
2004-05-07 |
2005-11-17 |
Taro Pharmaceutical Industries Ltd. |
Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
|
US20090170872A1
(en)
*
|
2005-07-05 |
2009-07-02 |
Orchid Research Laboratories Limited |
Compounds and Their Pharmaceutical Use
|
US8580730B2
(en)
|
2009-05-20 |
2013-11-12 |
(Inserm) Institut National De La Sante Et De La Recherche Medicale |
Methods of treating lesional vestibular disorders by administering serotonin 5-HT3 receptor antagonists
|
ES2432618T3
(es)
|
2009-05-20 |
2013-12-04 |
Inserm (Institut National De La Santé Et De La Recherche Medicale) |
Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
|
CN115611864A
(zh)
*
|
2022-11-01 |
2023-01-17 |
常州兰陵制药有限公司 |
一种昂丹司琼类化合物及其制备方法与应用
|
GB202301322D0
(en)
|
2023-01-30 |
2023-03-15 |
Therakind Ltd |
Antiemetic pharmaceutical compositions for nasal delivery
|